ID   PLM_RAT                 Reviewed;          92 AA.
AC   O08589;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   30-AUG-2002, sequence version 2.
DT   29-MAY-2024, entry version 159.
DE   RecName: Full=Phospholemman {ECO:0000250|UniProtKB:P56513};
DE   AltName: Full=FXYD domain-containing ion transport regulator 1 {ECO:0000312|RGD:69306};
DE   AltName: Full=Sodium/potassium-transporting ATPase subunit FXYD1 {ECO:0000305};
DE   Flags: Precursor;
GN   Name=Fxyd1 {ECO:0000312|RGD:69306};
GN   Synonyms=Plm {ECO:0000303|PubMed:9169143};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Heart;
RX   PubMed=9169143; DOI=10.1006/geno.1997.4665;
RA   Chen L.-S.K., Lo C.F., Numann R., Cuddy M.;
RT   "Characterization of the human and rat phospholemman (PLM) cDNAs and
RT   localization of the human PLM gene to chromosome 19q13.1.";
RL   Genomics 41:435-443(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=10950925; DOI=10.1006/geno.2000.6274;
RA   Sweadner K.J., Rael E.;
RT   "The FXYD gene family of small ion transport regulators or channels: cDNA
RT   sequence, protein signature sequence, and expression.";
RL   Genomics 68:41-56(2000).
RN   [3]
RP   PROTEIN SEQUENCE OF 70-81, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   STRAIN=Sprague-Dawley; TISSUE=Brain;
RA   Lubec G., Kang S.U., Lubec S.;
RL   Submitted (SEP-2007) to UniProtKB.
RN   [4]
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=12657675; DOI=10.1523/jneurosci.23-06-02161.2003;
RA   Feschenko M.S., Donnet C., Wetzel R.K., Asinovski N.K., Jones L.R.,
RA   Sweadner K.J.;
RT   "Phospholemman, a single-span membrane protein, is an accessory protein of
RT   Na,K-ATPase in cerebellum and choroid plexus.";
RL   J. Neurosci. 23:2161-2169(2003).
RN   [5]
RP   FUNCTION, INTERACTION WITH ATP1A1, DOMAIN, AND ROLE OF PHOSPHORYLATION AT
RP   SER-88.
RX   PubMed=17283221; DOI=10.1096/fj.06-7269com;
RA   Pavlovic D., Fuller W., Shattock M.J.;
RT   "The intracellular region of FXYD1 is sufficient to regulate cardiac Na/K
RT   ATPase.";
RL   FASEB J. 21:1539-1546(2007).
RN   [6]
RP   INTERACTION WITH ATP1A1, AND PHOSPHORYLATION AT SER-83; SER-88 AND THR-89.
RX   PubMed=19339511; DOI=10.1152/ajpcell.00523.2008;
RA   Fuller W., Howie J., McLatchie L.M., Weber R.J., Hastie C.J., Burness K.,
RA   Pavlovic D., Shattock M.J.;
RT   "FXYD1 phosphorylation in vitro and in adult rat cardiac myocytes:
RT   threonine 69 is a novel substrate for protein kinase C.";
RL   Am. J. Physiol. 296:C1346-C1355(2009).
RN   [7]
RP   TISSUE SPECIFICITY, AND DEVELOPMENTAL STAGE.
RX   PubMed=19187398; DOI=10.1111/j.1365-2826.2008.01812.x;
RA   Garcia-Rudaz C., Deng V., Matagne V., Ronnekleiv O.K., Bosch M., Han V.,
RA   Percy A.K., Ojeda S.R.;
RT   "FXYD1, a modulator of Na,K-ATPase activity, facilitates female sexual
RT   development by maintaining gonadotrophin-releasing hormone neuronal
RT   excitability.";
RL   J. Neuroendocrinol. 21:108-122(2009).
RN   [8]
RP   INTERACTION WITH ATP1A1; ATP1A2; ATP1A3 AND ATP1B1, SUBCELLULAR LOCATION,
RP   AND PHOSPHORYLATION AT SER-83 AND SER-88.
RX   PubMed=23532852; DOI=10.1074/jbc.m113.460956;
RA   Wypijewski K.J., Howie J., Reilly L., Tulloch L.B., Aughton K.L.,
RA   McLatchie L.M., Shattock M.J., Calaghan S.C., Fuller W.;
RT   "A separate pool of cardiac phospholemman that does not regulate or
RT   associate with the sodium pump: multimers of phospholemman in ventricular
RT   muscle.";
RL   J. Biol. Chem. 288:13808-13820(2013).
CC   -!- FUNCTION: Associates with and regulates the activity of the
CC       sodium/potassium-transporting ATPase (NKA) which transports Na(+) out
CC       of the cell and K(+) into the cell (By similarity). Inhibits NKA
CC       activity in its unphosphorylated state and stimulates activity when
CC       phosphorylated (PubMed:17283221). Reduces glutathionylation of the NKA
CC       beta-1 subunit ATP1B1, thus reversing glutathionylation-mediated
CC       inhibition of ATP1B1 (By similarity). Contributes to female sexual
CC       development by maintaining the excitability of neurons which secrete
CC       gonadotropin-releasing hormone (By similarity).
CC       {ECO:0000250|UniProtKB:P56513, ECO:0000250|UniProtKB:Q9Z239,
CC       ECO:0000269|PubMed:17283221}.
CC   -!- SUBUNIT: Homotetramer (By similarity). Monomer (By similarity).
CC       Regulatory subunit of the sodium/potassium-transporting ATPase (NKA)
CC       which is composed of a catalytic alpha subunit, a non-catalytic beta
CC       subunit and an additional regulatory subunit (By similarity). The
CC       monomeric form associates with NKA while the oligomeric form does not
CC       (By similarity). Interacts with the catalytic alpha-1 subunit ATP1A1
CC       (PubMed:17283221, PubMed:19339511, PubMed:23532852). Also interacts
CC       with the catalytic alpha-2 and alpha-3 subunits ATP1A2 and ATP1A3
CC       (PubMed:23532852). Very little interaction with ATP1A1, ATP1A2 or
CC       ATP1A3 when phosphorylated at Ser-83 (PubMed:23532852). Interacts with
CC       the non-catalytic beta-1 subunit ATP1B1 (PubMed:23532852). Oxidative
CC       stress decreases interaction with ATP1A1 but increases interaction with
CC       ATP1B1 (By similarity). {ECO:0000250|UniProtKB:O00168,
CC       ECO:0000250|UniProtKB:P56513, ECO:0000250|UniProtKB:Q3SZX0,
CC       ECO:0000250|UniProtKB:Q9Z239, ECO:0000269|PubMed:17283221,
CC       ECO:0000269|PubMed:19339511, ECO:0000269|PubMed:23532852}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane, sarcolemma
CC       {ECO:0000269|PubMed:23532852}; Single-pass type I membrane protein
CC       {ECO:0000255}. Apical cell membrane {ECO:0000269|PubMed:12657675};
CC       Single-pass type I membrane protein {ECO:0000255}. Membrane, caveola
CC       {ECO:0000269|PubMed:23532852}. Cell membrane, sarcolemma, T-tubule
CC       {ECO:0000269|PubMed:23532852}. Note=Detected in the apical cell
CC       membrane in brain (PubMed:12657675). In myocytes, localizes to
CC       sarcolemma, t-tubules and intercalated disks (PubMed:23532852).
CC       {ECO:0000269|PubMed:12657675, ECO:0000269|PubMed:23532852}.
CC   -!- TISSUE SPECIFICITY: In adult brain, highest levels are found in the
CC       cerebellum and in the lateral, third and fourth ventricles of the
CC       choroid plexus (at protein level) (PubMed:12657675). Also detected in
CC       cells of a portion of the ependymal lining of the lateral ventricle on
CC       its rostral surface posterior to the caudate putamen (at protein level)
CC       (PubMed:12657675). Expressed in a subset of neurons which secrete
CC       gonadotropin-releasing hormone (PubMed:19187398).
CC       {ECO:0000269|PubMed:12657675, ECO:0000269|PubMed:19187398}.
CC   -!- DEVELOPMENTAL STAGE: In the medial basal hypothalamus, levels are low
CC       at birth and increase during neonatal and infantile development to
CC       reach a maximum during the mid-to-late juvenile period at postnatal
CC       days 24-30. {ECO:0000269|PubMed:19187398}.
CC   -!- DOMAIN: The cytoplasmic domain is sufficient to regulate
CC       sodium/potassium-transporting ATPase activity.
CC       {ECO:0000269|PubMed:17283221}.
CC   -!- PTM: Major plasma membrane substrate for cAMP-dependent protein kinase
CC       (PKA) and protein kinase C (PKC) in several different tissues (By
CC       similarity). Phosphorylated in response to insulin and adrenergic
CC       stimulation (By similarity). Phosphorylation at Ser-88 stimulates
CC       sodium/potassium-transporting ATPase activity while the
CC       unphosphorylated form inhibits sodium/potassium-transporting ATPase
CC       activity (PubMed:17283221). Phosphorylation increases tetramerization,
CC       decreases binding to ATP1A1 and reduces inhibition of ATP1A1 activity
CC       (By similarity). Phosphorylation at Ser-83 leads to greatly reduced
CC       interaction with ATP1A1, ATP1A2 and ATP1A3 (PubMed:23532852). May be
CC       phosphorylated by DMPK (By similarity). {ECO:0000250|UniProtKB:O00168,
CC       ECO:0000250|UniProtKB:P56513, ECO:0000269|PubMed:17283221,
CC       ECO:0000269|PubMed:23532852}.
CC   -!- PTM: Palmitoylation increases half-life and stability and is enhanced
CC       upon phosphorylation at Ser-88 by PKA. {ECO:0000250|UniProtKB:O00168}.
CC   -!- SIMILARITY: Belongs to the FXYD family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U72246; AAC53169.1; -; mRNA.
DR   RefSeq; XP_006228901.1; XM_006228839.3.
DR   RefSeq; XP_008757406.1; XM_008759184.2.
DR   RefSeq; XP_017445120.1; XM_017589631.1.
DR   AlphaFoldDB; O08589; -.
DR   SMR; O08589; -.
DR   IntAct; O08589; 2.
DR   STRING; 10116.ENSRNOP00000028624; -.
DR   iPTMnet; O08589; -.
DR   PhosphoSitePlus; O08589; -.
DR   SwissPalm; O08589; -.
DR   PaxDb; 10116-ENSRNOP00000028624; -.
DR   GeneID; 58971; -.
DR   UCSC; RGD:69306; rat.
DR   AGR; RGD:69306; -.
DR   CTD; 5348; -.
DR   RGD; 69306; Fxyd1.
DR   eggNOG; ENOG502S5XM; Eukaryota.
DR   HOGENOM; CLU_171208_2_0_1; -.
DR   InParanoid; O08589; -.
DR   OrthoDB; 4642382at2759; -.
DR   PhylomeDB; O08589; -.
DR   TreeFam; TF333443; -.
DR   Reactome; R-RNO-5578775; Ion homeostasis.
DR   Reactome; R-RNO-936837; Ion transport by P-type ATPases.
DR   PRO; PR:O08589; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0016324; C:apical plasma membrane; IDA:UniProtKB.
DR   GO; GO:0005901; C:caveola; IDA:RGD.
DR   GO; GO:0014704; C:intercalated disc; IDA:UniProtKB.
DR   GO; GO:0042383; C:sarcolemma; IDA:RGD.
DR   GO; GO:0005890; C:sodium:potassium-exchanging ATPase complex; ISS:UniProtKB.
DR   GO; GO:0030315; C:T-tubule; IDA:UniProtKB.
DR   GO; GO:0051117; F:ATPase binding; IDA:RGD.
DR   GO; GO:0017022; F:myosin binding; IDA:RGD.
DR   GO; GO:0017080; F:sodium channel regulator activity; ISO:RGD.
DR   GO; GO:0010734; P:negative regulation of protein glutathionylation; ISS:UniProtKB.
DR   GO; GO:1903797; P:positive regulation of inorganic anion transmembrane transport; IMP:RGD.
DR   GO; GO:0032892; P:positive regulation of organic acid transport; IMP:RGD.
DR   GO; GO:1903278; P:positive regulation of sodium ion export across plasma membrane; ISS:UniProtKB.
DR   GO; GO:0006813; P:potassium ion transport; IEA:UniProtKB-KW.
DR   GO; GO:0086004; P:regulation of cardiac muscle cell contraction; IMP:RGD.
DR   GO; GO:0086036; P:regulation of cardiac muscle cell membrane potential; ISO:RGD.
DR   GO; GO:0051480; P:regulation of cytosolic calcium ion concentration; IMP:RGD.
DR   GO; GO:0006814; P:sodium ion transport; IEA:UniProtKB-KW.
DR   CDD; cd20317; FXYD1; 1.
DR   Gene3D; 1.20.5.780; Single helix bin; 1.
DR   InterPro; IPR047297; FXYD_motif.
DR   InterPro; IPR000272; Ion-transport_regulator_FXYD.
DR   InterPro; IPR047281; PLM.
DR   PANTHER; PTHR14132:SF12; PHOSPHOLEMMAN; 1.
DR   PANTHER; PTHR14132; SODIUM/POTASSIUM-TRANSPORTING ATPASE SUBUNIT GAMMA; 1.
DR   Pfam; PF02038; ATP1G1_PLM_MAT8; 1.
DR   PROSITE; PS01310; FXYD; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Direct protein sequencing; Glutathionylation; Ion transport;
KW   Lipoprotein; Membrane; Palmitate; Phosphoprotein; Potassium;
KW   Potassium transport; Reference proteome; Signal; Sodium; Sodium transport;
KW   Sodium/potassium transport; Transmembrane; Transmembrane helix; Transport.
FT   SIGNAL          1..20
FT                   /evidence="ECO:0000250|UniProtKB:P56513"
FT   CHAIN           21..92
FT                   /note="Phospholemman"
FT                   /id="PRO_0000010361"
FT   TOPO_DOM        21..35
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        36..56
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        57..92
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   REGION          66..92
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        68..84
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         62
FT                   /note="S-glutathionyl cysteine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P56513"
FT   MOD_RES         79
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Z239"
FT   MOD_RES         82
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Z239"
FT   MOD_RES         83
FT                   /note="Phosphoserine; by PKA and PKC"
FT                   /evidence="ECO:0000269|PubMed:19339511,
FT                   ECO:0000269|PubMed:23532852"
FT   MOD_RES         88
FT                   /note="Phosphoserine; by PKA"
FT                   /evidence="ECO:0000269|PubMed:19339511,
FT                   ECO:0000269|PubMed:23532852"
FT   MOD_RES         89
FT                   /note="Phosphothreonine; by PKC"
FT                   /evidence="ECO:0000269|PubMed:19339511"
FT   LIPID           60
FT                   /note="S-palmitoyl cysteine"
FT                   /evidence="ECO:0000250|UniProtKB:O00168"
FT   LIPID           62
FT                   /note="S-palmitoyl cysteine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:O00168"
FT   CONFLICT        3..5
FT                   /note="SPG -> PLH (in Ref. 1; AAC53169)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        43..46
FT                   /note="IAGI -> AGIL (in Ref. 1; AAC53169)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   92 AA;  10365 MW;  29530D084B3CB7C2 CRC64;
     MASPGHILIV CVCLLSMASA EAPQEPDPFT YDYHTLRIGG LTIAGILFIL GILIILSKRC
     RCKFNQQQRT GEPDEEEGTF RSSIRRLSTR RR
//
